Literature DB >> 22487214

Expressed protein ligation-mediated template protein extension.

Ayako Kamei1, Paul S Hauser, Jennifer A Beckstead, Paul M M Weers, Robert O Ryan.   

Abstract

Expressed protein ligation (EPL) was performed to investigate sequence requirements for a variant human apolipoprotein A-I (apoA-I) to adopt a folded structure. A C-terminal truncated apoA-I, corresponding to residues 1-172, was expressed and isolated from Escherichia coli. Compared to full length apoA-I (243 amino acids), apoA-I(1-172) displayed less α-helix secondary structure and lower stability in solution. To determine if extension of this polypeptide would confer secondary structure content and/or stability, 20 residues were added to the C-terminus of apoA-I(1-172) by EPL, creating apoA-I(Milano)(1-192). The EPL product displayed biophysical properties similar to full-length apoA-I(Milano). The results provide a general protein engineering strategy to modify the length of a recombinant template polypeptide using synthetic peptides as well as a convenient, cost effective way to investigate the structure/function relations in apolipoprotein fragments or domains of different size.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487214      PMCID: PMC3361518          DOI: 10.1016/j.pep.2012.03.014

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  22 in total

Review 1.  Intein-mediated ligation and cyclization of expressed proteins.

Authors:  M Q Xu; T C Evans
Journal:  Methods       Date:  2001-07       Impact factor: 3.608

2.  Autoregulation of a bacterial sigma factor explored by using segmental isotopic labeling and NMR.

Authors:  Julio A Camarero; Alexander Shekhtman; Elizabeth A Campbell; Mark Chlenov; Tanja M Gruber; Donald A Bryant; Seth A Darst; David Cowburn; Tom W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

3.  Merging fluorescence resonance energy transfer and expressed protein ligation to analyze protein-protein interactions.

Authors:  Kara A Scheibner; Zhongsen Zhang; Philip A Cole
Journal:  Anal Biochem       Date:  2003-06-15       Impact factor: 3.365

4.  Expressed protein ligation to probe regiospecificity of heterocyclization in the peptide antibiotic microcin B17.

Authors:  R S Roy; O Allen; C T Walsh
Journal:  Chem Biol       Date:  1999-11

5.  Protein tyrosine kinase Csk-catalyzed phosphorylation of Src containing unnatural tyrosine analogues.

Authors:  D Wang; P A Cole
Journal:  J Am Chem Soc       Date:  2001-09-19       Impact factor: 15.419

6.  Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization.

Authors:  Xiaohu Mei; David Atkinson
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

7.  Semisynthesis and folding of the potassium channel KcsA.

Authors:  Francis I Valiyaveetil; Roderick MacKinnon; Tom W Muir
Journal:  J Am Chem Soc       Date:  2002-08-07       Impact factor: 15.419

8.  Cellular stabilization of the melatonin rhythm enzyme induced by nonhydrolyzable phosphonate incorporation.

Authors:  Weiping Zheng; Zhongsen Zhang; Surajit Ganguly; Joan L Weller; David C Klein; Philip A Cole
Journal:  Nat Struct Biol       Date:  2003-10-26

9.  2,3-difluorotyrosine at position 356 of ribonucleotide reductase R2: a probe of long-range proton-coupled electron transfer.

Authors:  Cyril S Yee; Michelle C Y Chang; Jie Ge; Daniel G Nocera; JoAnne Stubbe
Journal:  J Am Chem Soc       Date:  2003-09-03       Impact factor: 15.419

10.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Authors:  Steven E Nissen; Taro Tsunoda; E Murat Tuzcu; Paul Schoenhagen; Christopher J Cooper; Muhammad Yasin; Gregory M Eaton; Michael A Lauer; W Scott Sheldon; Cindy L Grines; Stephen Halpern; Tim Crowe; James C Blankenship; Richard Kerensky
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.